ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Waiting lists"

  • 2017 American Transplant Congress

    Association Between Transportation Strategies and Kidney Transplant Center Staff Perceived Racial Disparities.

    K. Lipford, L. McPherson, R. Hamoda, R. Patzer.

    Department of Surgery, Emory University, Atlanta, GA

    Background: Racial disparities exist in access to the transplant evaluation process. One contributing factor for this disparity is travel barriers. Transplant center policies to assist…
  • 2017 American Transplant Congress

    Transplantation of Organs from Donors with Hepatitis C: The Potential to Substantially Increase Transplant Activity.

    P. Trotter,1,2 M. Robb,2 I. Ushiro-Lumb,2 J. Powell,3 C. Watson,1 J. Bradley,1 J. Neuberger.2,4

    1Department of Surgery, University of Cambridge, Cambridge, United Kingdom; 2Organ Donation and Transplantation, National Health Service Blood and Transplant, Bristol, United Kingdom; 3Hepatic-Pancreatico-Biliary Surgical Services and Edinburgh Transplant Unit, Royal Infirmary Edinburgh, Edinburgh, United Kingdom; 4The Liver Unit, Queen Elizabeth Hospital, Birmingham, United Kingdom

    Introduction. Organs from hepatitis C virus positive (HCV+ve) donors are commonly declined for transplantation because of the risk of disease transmission, but new direct acting…
  • 2017 American Transplant Congress

    Kidney Allograft Offers: Predictors of Turndown and the Relationship of Organ Acceptance Sequence to Kidney Allograft Survival.

    J. Cohen,1,2 J. Shults,2 D. Goldberg,2,3 D. Sawinski,1 P. Abt,4 P. Reese.1,2

    1Renal Division, University of Pennsylvania, Philadelphia, PA; 2Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA; 3Division of Gastroenterology, University of Pennsylvania, Philadelphia, PA; 4Transplant Surgery, University of Pennsylvania, Philadelphia, PA

    Background: There is growing interest in understanding patterns of organ acceptance and reducing organ discard. Little is known about how donor factors, holidays, and location…
  • 2017 American Transplant Congress

    Waitlist Outcomes of Patients Re-Listed Following Failed Donation After Cardiac Death (DCD) Liver Transplant.

    K. Croome, D. Lee, A. Keaveny, C. Taner.

    Transplant, Mayo Clinic Florida, Jacksonville, FL

    Introduction: The outcome for patients re-listed after developing ischemic cholangiopathy(IC) or graft failure following liver transplant(LT) from a DCD donor, remains a significant concern. Better…
  • 2017 American Transplant Congress

    Treating Hepatitis C+ Patients Before or After Kidney Transplantation: A Medical Decision Analysis.

    B. Kiberd,1 K. Tennankore,1 K. Doucette.2

    1Medicine, Dalhousie University, Halifax, NS, Canada; 2Medicine, University of Alberta, Edmonton, AB, Canada

    Some have recommended that HCV+ kidney wait list patients delay HCV treatment with direct acting antiviral agents (DAAs) with the option of receiving an HCV+/HCV-…
  • 2017 American Transplant Congress

    A Multistate Modeling Analysis of Time-Varying CPRA States and Its Impact on Kidney Transplant: A Focus on KAS Implementation.

    S. Kulkarni,1 I. Hall,2 R. Formica,1 D. Stewart,3 E. Greene,4 Y. Deng.4

    1Surgery & Medicine, Yale School of Medicine, New Haven, CT; 2Medicine, Utah School of Medicine, Salt Lake City, UT; 3United Network of Organ Sharing, Richmond, VA; 4Center for Analytical Sciences, Yale School of Public Health, New Haven, CT

    Background: Highly sensitized kidney transplant candidates are at higher risk of death on the waiting list(WL). OPTN policy change 8(Kidney Allocation System(KAS)) aimed to improve…
  • 2017 American Transplant Congress

    Regional Variation in Liver Donor Utilization Across the U.S.

    A. Friedman,1 P. Bagavan,2 S. Florman,3 H. Irving,1 B. Samstein,4 B. Schleich.1

    1LiveOnNY, New York, NY; 2Binghamton University, Binghamton, NY; 3Recanati/Miller Transplant Institute, New York, NY; 4Weill Cornell Medical College, New York, NY

    Unequal patient access to deceased donor liver transplantation across the U.S. has generated efforts to redesign the allocation system. Geographic disparities include the severity of…
  • 2017 American Transplant Congress

    HCC and Liver Transplantation Following the Recent Allocation Policy Change.

    T. Ishaque, A. Massie, M. Bowring, J. Ruck, A. Cameron, B. Philosophe, D. Segev.

    Johns Hopkins University, Baltimore

    In October 2015, OPTN implemented a revised liver allocation policy to address the disparity between HCC and non-HCC patients in access to deceased-donor liver transplant…
  • 2017 American Transplant Congress

    Impact of a Novel Prehabilitation Program in Kidney Transplant Candidates.

    M. McAdams DeMarco, H. Ying, A. Nastasi, D. Segev.

    Johns Hopkins, Baltimore, MD

    Background: Prehabilitation is the process of enhancing surgical patient functional capacity prior to surgery to improve tolerance for the upcoming physiologic stress. While prehabilitation has…
  • 2017 American Transplant Congress

    WHO Group II Pulmonary Hypertension Is Associated with Decreased Survival in Patients Awaiting Liver Transplantation.

    H. Memon, J.-A. Guerra, B. Trachtenberg, J. Estep, A. Bhimaraj, I. Hussain, M. Park, H. Monsour, M. Ghobrial, A. Guha.

    Medicine, Houston Methodist Hospital, Houston, TX

    End stage liver disease (ESLD) patients with cirrhotic cardiomyopathy often have WHO Group II pulmonary hypertension (PH), characterized by pulmonary capillary wedge pressure (PCWP) >15…
  • « Previous Page
  • 1
  • …
  • 31
  • 32
  • 33
  • 34
  • 35
  • …
  • 44
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences